Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics
Müller K, Falck G (2018)
Antibodies 7(1): 4.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
antibodies-07-00004.mueller.pdf
1.44 MB
Autor*in
Abstract / Bemerkung
Strategies for site-specific modification of proteins have increased in number, complexity, and specificity over the last years. Such modifications hold the promise to broaden the use of existing biopharmaceuticals or to tailor novel proteins for therapeutic or diagnostic applications. The recent quest for next-generation antibody–drug conjugates (ADCs) sparked research into techniques with site selectivity. While purely chemical approaches often impede control of dosage or locus of derivatization, naturally occurring enzymes and proteins bear the ability of co- or post-translational protein modifications at particular residues, thus enabling unique coupling reactions or protein fusions. This review provides a general overview and focuses on chemo-enzymatic methods including enzymes such as formylglycine-generating enzyme, sortase, and transglutaminase. Applications for the conjugation of antibodies and antibody mimetics are reported. View Full-Text
Stichworte
chemo-enzymatic labeling;
armed antibody;
antibody coupling;
antibody conjugation
Erscheinungsjahr
2018
Zeitschriftentitel
Antibodies
Band
7
Ausgabe
1
Art.-Nr.
4
Urheberrecht / Lizenzen
ISSN
2073-4468
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2917494
Zitieren
Müller K, Falck G. Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies. 2018;7(1): 4.
Müller, K., & Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies, 7(1), 4. doi:10.3390/antib7010004
Müller, Kristian, and Falck, Georg. 2018. “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”. Antibodies 7 (1): 4.
Müller, K., and Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies 7:4.
Müller, K., & Falck, G., 2018. Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies, 7(1): 4.
K. Müller and G. Falck, “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”, Antibodies, vol. 7, 2018, : 4.
Müller, K., Falck, G.: Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies. 7, : 4 (2018).
Müller, Kristian, and Falck, Georg. “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”. Antibodies 7.1 (2018): 4.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
antibodies-07-00004.mueller.pdf
1.44 MB
Access Level
Open Access
Zuletzt Hochgeladen
2019-09-06T09:18:56Z
MD5 Prüfsumme
173fcb905872acb2966b97efc3d68f94
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 31544857
PubMed | Europe PMC
Suchen in